Table 2.
Effects of moderators
| Variables | Coefficienta | SE | DOR | 95% CI of DOR | p b | |
|---|---|---|---|---|---|---|
| Number of patient (> 24 vs ≤ 24) | 0.510 | 1.9013 | 1.67 | 0.00 | 5949.91 | 0.8136 |
| Study design (prospective vs retrospective) | − 0.794 | 1.8604 | 0.45 | 0.00 | 1353.44 | 0.7110 |
| PTH level (> 132 vs ≤132 pg/ml) | 0.813 | 1.4965 | 2.25 | 0.00 | 1410.16 | 0.6415 |
| Patient type (primary vs primary and secondary) | − 0.672 | 1.9449 | 0.51 | 0.00 | 2200.65 | 0.7627 |
Number of patient (1 (> 24) vs 0 (≤ 24)); study design (1 (prospective) vs 0 (petrospective)), PTH level (> 132 vs ≤ 132 pg/ml), patient type (primary vs primary and secondary)
DOR diagnostic odds ratio, SE standard error, CI confidence interval
aRegression coefficient
bP value of random effect meta-regression using maximum likelihood estimation (ML) between-study variances and the weighted least squares of study size for regression model estimation